Browse by Changes
Summary of Changes – 1 May 2025
Page last updated: 1 May 2025
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Prescriber Bag
- Additions
- Deletions
- Alterations
- Supply Only
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Community Access)
- IVF Program
- Repatriation Pharmaceutical Benefits
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
Prescriber Bag
Advance Notices
1 June 2025
Deletion – Brand
13801J | Extencilline Benzathine Benzylpenicillin (France), YO – BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack |
General Pharmaceutical Benefits
Additions
Addition – Item
14797T | AMINO ACID FORMULA WITH FAT, CARBOHYDRATE, VITAMINS, MINERALS, TRACE ELEMENTS AND MEDIUM CHAIN TRIGLYCERIDES, amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides powder for oral liquid, 400 g (Essential Care Jr) |
14825G | AMINO ACID FORMULA WITH FAT, CARBOHYDRATE, VITAMINS, MINERALS, TRACE ELEMENTS AND MEDIUM CHAIN TRIGLYCERIDES, amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides powder for oral liquid, 400 g (Essential Care Jr) |
14790K | ARIPIPRAZOLE, aripiprazole 720 mg/2.4 mL modified release injection, 2.4 mL syringe (Abilify Asimtufii) |
14824F | ARIPIPRAZOLE, aripiprazole 960 mg/3.2 mL modified release injection, 3.2 mL syringe (Abilify Asimtufii) |
14832P | CLOBETASOL, clobetasol propionate 0.05% cream, 30 g (Xobet) |
14808J | CLOBETASOL, clobetasol propionate 0.05% ointment, 30 g (Xobet) |
14791L | DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 4 x 28 (Slinda) |
14792M | EPCORITAMAB, epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
14809K | EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
14819Y | EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
14786F | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations (Spravato) |
14794P | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations (Spravato) |
14812N | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 actuations (Spravato) |
14815R | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations (Spravato) |
14830M | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations (Spravato) |
14836W | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 actuations (Spravato) |
14788H | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Vabysmo) |
14789J | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Vabysmo) |
14799X | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Vabysmo) |
14817W | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Vabysmo) |
14833Q | FENFLURAMINE, fenfluramine hydrochloride 2.2 mg/mL oral liquid, 360 mL (Fintepla) |
14820B | GLYCOMACROPEPTIDE AND ESSENTIAL AMINO ACIDS WITH VITAMINS AND MINERALS, glycomacropeptide and essential amino acids with vitamins and minerals containing 10 g of protein equivalent powder for oral liquid, 30 x 15 g sachets (PKU Build 10) |
14818X | PRASUGREL, prasugrel 5 mg tablet, 28 (Prasugrel Lupin) |
14796R | PRASUGREL, prasugrel 10 mg tablet, 28 (Prasugrel Lupin) |
14793N | PRAZOSIN, prazosin 1 mg capsule, 100 (Prazosin Hydrochloride Capsules, USP 1 mg (Novitium Pharma, USA)) |
14834R | PRAZOSIN, prazosin 1 mg capsule, 100 (Prazosin Hydrochloride Capsules, USP 1 mg (Novitium Pharma, USA)) |
14795Q | RELUGOLIX + ESTRADIOL + NORETHISTERONE ACETATE, relugolix 40 mg + estradiol 1 mg + norethisterone acetate 500 microgram tablet, 28 (Ryeqo) |
Addition – Brand
13440J | ARX-EZETIMIBE, XT – EZETIMIBE, ezetimibe 10 mg tablet, 30 |
8757X | ARX-EZETIMIBE, XT – EZETIMIBE, ezetimibe 10 mg tablet, 30 |
1242J | ORIDOPA 100/25, OX – LEVODOPA + CARBIDOPA, levodopa 100 mg + carbidopa 25 mg tablet, 100 |
14427H | ORIDOPA 100/25, OX – LEVODOPA + CARBIDOPA, levodopa 100 mg + carbidopa 25 mg tablet, 100 |
13510C | Nebaloc, CR – NEBIVOLOL, nebivolol 5 mg tablet, 28 |
9311C | Nebaloc, CR – NEBIVOLOL, nebivolol 5 mg tablet, 28 |
13441K | Nebaloc, CR – NEBIVOLOL, nebivolol 10 mg tablet, 28 |
9312D | Nebaloc, CR – NEBIVOLOL, nebivolol 10 mg tablet, 28 |
8814X | Chemists' Own Osteo Relief Paracetamol, RF – PARACETAMOL, paracetamol 665 mg modified release tablet, 96 |
11633G | RIVAXIB, MQ – RIVAROXABAN, rivaroxaban 10 mg tablet, 30 |
13521P | RIVAXIB, MQ – RIVAROXABAN, rivaroxaban 10 mg tablet, 30 |
9467G | RIVAXIB, MQ – RIVAROXABAN, rivaroxaban 10 mg tablet, 30 |
13463N | RIVAXIB, MQ – RIVAROXABAN, rivaroxaban 15 mg tablet, 28 |
2160Q | RIVAXIB, MQ – RIVAROXABAN, rivaroxaban 15 mg tablet, 42 |
2691P | RIVAXIB, MQ – RIVAROXABAN, rivaroxaban 15 mg tablet, 28 |
13462M | RIVAXIB, MQ – RIVAROXABAN, rivaroxaban 20 mg tablet, 28 |
2268J | RIVAXIB, MQ – RIVAROXABAN, rivaroxaban 20 mg tablet, 28 |
11276L | TENOFOVIR/EMTRICITABINE 300/200 APX, XW – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
2180R | Tranexamic Acid Waymade, IX – TRANEXAMIC ACID, tranexamic acid 500 mg tablet, 100 |
Addition – Equivalence Indicator
13177M | Vabysmo, RO – FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
13183W | Vabysmo, RO – FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
13195L | Vabysmo, RO – FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
13198P | Vabysmo, RO – FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
Addition – Note
13553H | PRAZOSIN, prazosin 1 mg tablet, 100 (APO-Prazosin, Minipress) |
1479W | PRAZOSIN, prazosin 1 mg tablet, 100 (APO-Prazosin, Minipress) |
Deletions
Deletion – Item
1758M | CEFOTAXIME, cefotaxime 1 g injection, 10 vials (DBL Cefotaxime) |
1768C | CEFOTAXIME, cefotaxime 1 g injection, 10 vials (DBL Cefotaxime) |
2824P | GENTAMICIN, gentamicin 80 mg/2 mL injection, 10 x 2 mL ampoules (Pfizer Australia Pty Ltd) |
11739W | METHYLPREDNISOLONE, methylprednisolone 40 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber vial (Solu-Medrol) |
14203M | MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL (RA-Morph (NZ)) |
14220K | MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL (RA-Morph (NZ)) |
9447F | PRAZIQUANTEL, praziquantel 600 mg tablet, 8 (Biltricide) |
13128Y | TENECTEPLASE, tenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack (TNKase (Canada) Medsurge Healthcare Pty Ltd, TNKase (Canada)) |
2328M | TOBRAMYCIN, tobramycin 0.3% eye drops, 5 mL (Tobrex) |
5569D | TOBRAMYCIN, tobramycin 0.3% eye drops, 5 mL (Tobrex) |
2329N | TOBRAMYCIN, tobramycin 0.3% eye ointment, 3.5 g (Tobrex) |
5570E | TOBRAMYCIN, tobramycin 0.3% eye ointment, 3.5 g (Tobrex) |
Deletion – Brand
8362D | Capecitabine Alphapharm, AF – CAPECITABINE, capecitabine 500 mg tablet, 120 |
8565T | Recagon, OV – FOLLITROPIN BETA, follitropin beta 300 units/0.36 mL injection, 0.36 mL cartridge |
8871X | Recagon, OV – FOLLITROPIN BETA, follitropin beta 900 units/1.08 mL injection, 1.08 mL cartridge |
13412X | Lercanidipine APOTEX, GX – LERCANIDIPINE, lercanidipine hydrochloride 20 mg tablet, 28 |
8679T | Lercanidipine APOTEX, GX – LERCANIDIPINE, lercanidipine hydrochloride 20 mg tablet, 28 |
5264C | Methylpred, AL – METHYLPREDNISOLONE, methylprednisolone 1 g injection, 1 vial |
13404L | Indosyl Mono 2, RW – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30 |
3050M | Indosyl Mono 2, RW – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30 |
13371R | Indosyl Mono 4, RW – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30 |
3051N | Indosyl Mono 4, RW – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30 |
13372T | Indosyl Mono 8, RW – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30 |
8704D | Indosyl Mono 8, RW – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30 |
13476G | Indosyl Combi 4/1.25, RW – PERINDOPRIL + INDAPAMIDE, perindopril erbumine 4 mg + indapamide hemihydrate 1.25 mg tablet, 30 |
8449Q | Indosyl Combi 4/1.25, RW – PERINDOPRIL + INDAPAMIDE, perindopril erbumine 4 mg + indapamide hemihydrate 1.25 mg tablet, 30 |
14421B | Optix, PP – POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL, polyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL |
5524R | Optix, PP – POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL, polyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL |
8676P | Optix, PP – POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL, polyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL |
Deletion – Equivalence Indicator
8565T | Puregon 300 IU/0.36 mL, OQ – FOLLITROPIN BETA, follitropin beta 300 units/0.36 mL injection, 0.36 mL cartridge |
8871X | Puregon 900 IU/1.08 mL, OQ – FOLLITROPIN BETA, follitropin beta 900 units/1.08 mL injection, 1.08 mL cartridge |
5264C | Solu-Medrol, PF – METHYLPREDNISOLONE, methylprednisolone 1 g injection, 1 vial |
2123R | Ordine 5, XT – MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL |
5238Q | Ordine 5, XT – MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL |
14421B | Systane, AQ – POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL, polyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL |
5524R | Systane, AQ – POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL, polyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL |
8676P | Systane, AQ – POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL, polyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL |
8527T | Metalyse, BY – TENECTEPLASE, tenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack |
Deletion – Note
14123H | MAVACAMTEN, mavacamten 2.5 mg capsule, 28 (Camzyos) |
14113T | MAVACAMTEN, mavacamten 5 mg capsule, 28 (Camzyos) |
14138D | MAVACAMTEN, mavacamten 10 mg capsule, 28 (Camzyos) |
14124J | MAVACAMTEN, mavacamten 15 mg capsule, 28 (Camzyos) |
2123R | MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL (Ordine 5) |
5238Q | MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL (Ordine 5) |
10614P | RUXOLITINIB, ruxolitinib 5 mg tablet, 56 (Jakavi) |
10616R | RUXOLITINIB, ruxolitinib 5 mg tablet, 56 (Jakavi) |
10913J | RUXOLITINIB, ruxolitinib 10 mg tablet, 56 (Jakavi) |
10927D | RUXOLITINIB, ruxolitinib 10 mg tablet, 56 (Jakavi) |
8527T | TENECTEPLASE, tenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack (Metalyse) |
Alterations
Alteration – Note
13177M | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
13183W | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
13195L | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
13198P | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
10865W | FOLLITROPIN ALFA, follitropin alfa 75 units (5.5 microgram)/0.125 mL injection, 5 x 0.125 mL pen devices (Bemfola) |
10877L | FOLLITROPIN ALFA, follitropin alfa 150 units (11 microgram)/0.25 mL injection, 5 x 0.25 mL pen devices (Bemfola) |
10876K | FOLLITROPIN ALFA, follitropin alfa 225 units (16.5 microgram)/0.375 mL injection, 5 x 0.375 mL pen devices (Bemfola) |
12769C | FOLLITROPIN ALFA, follitropin alfa 300 units (22 microgram)/0.5 mL injection, 0.5 mL cartridge (Ovaleap) |
8713N | FOLLITROPIN ALFA, follitropin alfa 300 units (21.84 microgram)/0.48 mL injection, 0.48 mL pen device (Gonal-f Pen) |
12808D | FOLLITROPIN ALFA, follitropin alfa 450 units (33 microgram)/0.75 mL injection, 0.75 mL cartridge (Ovaleap) |
8714P | FOLLITROPIN ALFA, follitropin alfa 450 units (32.76 microgram)/0.72 mL injection, 0.72 mL pen device (Gonal-f Pen) |
12778M | FOLLITROPIN ALFA, follitropin alfa 900 units (66 microgram)/1.5 mL injection, 1.5 mL cartridge (Ovaleap) |
8715Q | FOLLITROPIN ALFA, follitropin alfa 900 units (65.52 microgram)/1.44 mL injection, 1.44 mL pen device (Gonal-f Pen) |
Alteration – Restriction
12362P | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Adalicip, Hadlima, Humira, Hyrimoz, Yuflyma) |
12378L | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma) |
9033K | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Abrilada, Amgevita, Hadlima, Hyrimoz) |
9101B | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
11335N | AFATINIB, afatinib 20 mg tablet, 28 (Giotrif) |
11341X | AFATINIB, afatinib 30 mg tablet, 28 (Giotrif) |
11359W | AFATINIB, afatinib 40 mg tablet, 28 (Giotrif) |
11329G | AFATINIB, afatinib 50 mg tablet, 28 (Giotrif) |
14755N | DABRAFENIB, dabrafenib 50 mg capsule, 120 (Tafinlar) |
14778T | DABRAFENIB, dabrafenib 50 mg capsule, 120 (Tafinlar) |
14754M | DABRAFENIB, dabrafenib 75 mg capsule, 120 (Tafinlar) |
14757Q | DABRAFENIB, dabrafenib 75 mg capsule, 120 (Tafinlar) |
14753L | DABRAFENIB, dabrafenib 10 mg dispersible tablet, 2 x 210 (Tafinlar) |
14773M | DABRAFENIB, dabrafenib 10 mg dispersible tablet, 2 x 210 (Tafinlar) |
10022L | ERLOTINIB, erlotinib 25 mg tablet, 30 (ERLOTINIB ARX, Erlotinib APOTEX, Erlotinib Sandoz) |
10020J | ERLOTINIB, erlotinib 100 mg tablet, 30 (ERLOTINIB ARX, Erlotinib APOTEX, Erlotinib Sandoz) |
10014C | ERLOTINIB, erlotinib 150 mg tablet, 30 (ERLOTINIB ARX, Erlotinib APOTEX, Erlotinib Sandoz) |
13177M | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
13183W | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
8769M | GEFITINIB, gefitinib 250 mg tablet, 30 (Cipla Gefitinib) |
14123H | MAVACAMTEN, mavacamten 2.5 mg capsule, 28 (Camzyos) |
14113T | MAVACAMTEN, mavacamten 5 mg capsule, 28 (Camzyos) |
14138D | MAVACAMTEN, mavacamten 10 mg capsule, 28 (Camzyos) |
14124J | MAVACAMTEN, mavacamten 15 mg capsule, 28 (Camzyos) |
12232T | OSIMERTINIB, osimertinib 80 mg tablet, 30 (Tagrisso) |
Alteration – Manufacturer Code
From | To | ||
11091R | Klarvanta – CALCIPOTRIOL + BETAMETHASONE DIPROPIONATE, calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% foam, 60 g | LG | XT |
13520N | Klarvanta – CALCIPOTRIOL + BETAMETHASONE DIPROPIONATE, calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% foam, 60 g | LG | XT |
2463P | Reminyl – GALANTAMINE, galantamine 8 mg modified release capsule, 28 | JC | IX |
8770N | Reminyl – GALANTAMINE, galantamine 8 mg modified release capsule, 28 | JC | IX |
2537M | Reminyl – GALANTAMINE, galantamine 16 mg modified release capsule, 28 | JC | IX |
8771P | Reminyl – GALANTAMINE, galantamine 16 mg modified release capsule, 28 | JC | IX |
2531F | Reminyl – GALANTAMINE, galantamine 24 mg modified release capsule, 28 | JC | IX |
8772Q | Reminyl – GALANTAMINE, galantamine 24 mg modified release capsule, 28 | JC | IX |
Supply Only
Supply Only – Period Commencing
12643K |
AMINO ACID FORMULA WITH FAT, CARBOHYDRATE, VITAMINS, MINERALS, TRACE ELEMENTS AND MEDIUM CHAIN TRIGLYCERIDES, amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides powder for oral liquid, 800 g (Essential Care Jr) |
12650T |
AMINO ACID FORMULA WITH FAT, CARBOHYDRATE, VITAMINS, MINERALS, TRACE ELEMENTS AND MEDIUM CHAIN TRIGLYCERIDES, amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides powder for oral liquid, 800 g (Essential Care Jr) |
11287C |
GLYCOMACROPEPTIDE AND ESSENTIAL AMINO ACIDS WITH VITAMINS AND MINERALS, glycomacropeptide and essential amino acids with vitamins and minerals containing 10 g of protein equivalent powder for oral liquid, 60 x 16 g sachets (PKU Build 10) |
12160B |
SIPONIMOD, siponimod 250 microgram tablet, 120 (Mayzent) |
Supply Only – Period Ending
9219F |
POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL, polyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL (Optix) |
Advance Notices
1 June 2025
Deletion – Brand
12340L | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12341M | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12342N | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12345R | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12347W | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12358K | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12362P | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12363Q | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12373F | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12375H | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12376J | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12377K | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12381P | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12383R | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12389C | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12390D | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12411F | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12412G | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12414J | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12425Y | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12428D | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12429E | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12432H | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12433J | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12446C | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12454L | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13211H | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13214L | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13215M | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13221W | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13223Y | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13224B | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13225C | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13226D | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13227E | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13230H | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13691N | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13703F | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13764K | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
14221L | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
14234E | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
14242N | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
14272E | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13790T | Extencilline Benzathine Benzylpenicillin (France), YO – BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack |
13816E | Extencilline Benzathine Benzylpenicillin (France), YO – BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack |
14338P | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 200 mg tablet, 100 |
14509P | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 100 mg tablet, 100 |
1706T | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 200 mg tablet, 100 |
1724R | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 200 mg tablet, 100 |
2422L | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 100 mg tablet, 100 |
5039F | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 100 mg tablet, 100 |
13883Q | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 25 mg capsule, 30 |
13910D | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 50 mg capsule, 30 |
13911E | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 100 mg capsule, 30 |
8658Q | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 25 mg capsule, 30 |
8659R | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 50 mg capsule, 30 |
8660T | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 100 mg capsule, 30 |
5096F | Dicloxacillin Mylan 250, AL – DICLOXACILLIN, dicloxacillin 250 mg capsule, 24 |
8121K | Dicloxacillin Mylan 250, AL – DICLOXACILLIN, dicloxacillin 250 mg capsule, 24 |
13472C | NOUMED FUROSEMIDE, VO – FUROSEMIDE, furosemide 40 mg tablet, 100 |
2412Y | NOUMED FUROSEMIDE, VO – FUROSEMIDE, furosemide 40 mg tablet, 100 |
14076W | pms-HYDROmorphone, DZ – HYDROMORPHONE, hydromorphone hydrochloride 1 mg/mL oral liquid, 500 mL |
14080C | pms-HYDROmorphone, DZ – HYDROMORPHONE, hydromorphone hydrochloride 1 mg/mL oral liquid, 500 mL |
5264C | Solu-Medrol, PF – METHYLPREDNISOLONE, methylprednisolone 1 g injection, 1 vial |
8187X | Olanzapine APOTEX, GX – OLANZAPINE, olanzapine 10 mg tablet, 28 |
1594X | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 4 mg tablet, 10 |
1595Y | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 8 mg tablet, 10 |
5471Y | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 8 mg orally disintegrating tablet, 4 |
5473C | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 8 mg orally disintegrating tablet, 10 |
8224W | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 4 mg tablet, 4 |
8225X | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 8 mg tablet, 4 |
13430W | Ramipril Winthrop, WA – RAMIPRIL, ramipril 10 mg capsule, 30 |
8470T | Ramipril Winthrop, WA – RAMIPRIL, ramipril 10 mg capsule, 30 |
13586C | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 10 mg tablet, 30 |
2628H | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 10 mg tablet, 30 |
13917L | Valprease 500, RW – VALPROATE, valproate sodium 500 mg enteric tablet, 100 |
14017R | Valprease 200, RW – VALPROATE, valproate sodium 200 mg enteric tablet, 100 |
2289L | Valprease 200, RW – VALPROATE, valproate sodium 200 mg enteric tablet, 100 |
2290M | Valprease 500, RW – VALPROATE, valproate sodium 500 mg enteric tablet, 100 |
1 July 2025
Deletion – Brand
1007B | Aciclovir APOTEX, TY – ACICLOVIR, aciclovir 200 mg tablet, 90 |
13358C | Allopurinol APOTEX, GX – ALLOPURINOL, allopurinol 100 mg tablet, 200 |
2600W | Allopurinol APOTEX, GX – ALLOPURINOL, allopurinol 100 mg tablet, 200 |
13532F | Amlodipine APOTEX, GX – AMLODIPINE, amlodipine 5 mg tablet, 30 |
2751T | Amlodipine APOTEX, GX – AMLODIPINE, amlodipine 5 mg tablet, 30 |
8844L | Bivalirudin APOTEX, TX – BIVALIRUDIN, bivalirudin 250 mg injection, 1 vial |
1288T | Maxidex, NV – DEXAMETHASONE, dexamethasone 0.1% eye drops, 5 mL |
5565X | Maxidex, NV – DEXAMETHASONE, dexamethasone 0.1% eye drops, 5 mL |
13385L | Zeklen 10/10 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 10 mg tablet, 30 |
13442L | Zeklen 10/20 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 20 mg tablet, 30 |
13535J | Zeklen 10/40 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 40 mg tablet, 30 |
13595M | Zeklen 10/80 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 80 mg tablet, 30 |
8881K | Zeklen 10/40 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 40 mg tablet, 30 |
8882L | Zeklen 10/80 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 80 mg tablet, 30 |
9483D | Zeklen 10/10 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 10 mg tablet, 30 |
9484E | Zeklen 10/20 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 20 mg tablet, 30 |
14740T | Glyade MR, AF – GLICLAZIDE, gliclazide 30 mg modified release tablet, 100 |
8535F | Glyade MR, AF – GLICLAZIDE, gliclazide 30 mg modified release tablet, 100 |
13848W | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 1 mg tablet, 30 |
13870B | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 2 mg tablet, 30 |
14020X | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 3 mg tablet, 30 |
14055R | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 4 mg tablet, 30 |
8450R | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 1 mg tablet, 30 |
8451T | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 2 mg tablet, 30 |
8452W | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 4 mg tablet, 30 |
8533D | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 3 mg tablet, 30 |
14335L | Minitran 15, IL – GLYCERYL TRINITRATE, glyceryl trinitrate 15 mg/24 hours patch, 30 |
8119H | Minitran 15, IL – GLYCERYL TRINITRATE, glyceryl trinitrate 15 mg/24 hours patch, 30 |
13940Q | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 10 mg tablet, 30 |
13998R | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 20 mg tablet, 30 |
14068K | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 10 mg tablet, 30 |
14069L | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 20 mg tablet, 30 |
5449T | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 10 mg tablet, 30 |
5450W | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 20 mg tablet, 30 |
8374R | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 10 mg tablet, 30 |
8375T | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 20 mg tablet, 30 |
13411W | Lercanidipine APOTEX, GX – LERCANIDIPINE, lercanidipine hydrochloride 10 mg tablet, 28 |
8534E | Lercanidipine APOTEX, GX – LERCANIDIPINE, lercanidipine hydrochloride 10 mg tablet, 28 |
13939P | Letrozole APOTEX, GX – LETROZOLE, letrozole 2.5 mg tablet, 30 |
8245Y | Letrozole APOTEX, GX – LETROZOLE, letrozole 2.5 mg tablet, 30 |
13937M | Levetiracetam Mylan, AL – LEVETIRACETAM, levetiracetam 1 g tablet, 60 |
13992K | Levetiracetam Mylan, AL – LEVETIRACETAM, levetiracetam 250 mg tablet, 60 |
8654L | Levetiracetam Mylan, AL – LEVETIRACETAM, levetiracetam 250 mg tablet, 60 |
8656N | Levetiracetam Mylan, AL – LEVETIRACETAM, levetiracetam 1 g tablet, 60 |
10526B | Latuda, SE – LURASIDONE, lurasidone hydrochloride 40 mg tablet, 30 |
10529E | Latuda, SE – LURASIDONE, lurasidone hydrochloride 80 mg tablet, 30 |
8170B | Olanzapine APOTEX, GX – OLANZAPINE, olanzapine 2.5 mg tablet, 28 |
11681T | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
12277E | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
14330F | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
14362X | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
14394N | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
8007K | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
8008L | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
13588E | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 20 mg tablet, 30 |
13589F | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 40 mg tablet, 30 |
2574L | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 20 mg tablet, 30 |
2594M | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 40 mg tablet, 30 |
11856B | Sevelamer Apotex, TX – SEVELAMER, sevelamer carbonate 800 mg tablet, 180 |
14027G | Sevelamer Apotex, TX – SEVELAMER, sevelamer carbonate 800 mg tablet, 180 |
1 August 2025
Deletion – Brand
1052J | Aciclovir APOTEX, TY – ACICLOVIR, aciclovir 800 mg tablet, 35 |
14526M | Montelukast Mylan, AF – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
8627C | Montelukast Mylan, AF – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
Palliative Care
Additions
Addition – Brand
5343F | Chemists' Own Osteo Relief Paracetamol, RF – PARACETAMOL, paracetamol 665 mg modified release tablet, 96 |
Deletions
Deletion – Item
14186P | MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL (RA-Morph (NZ)) |
Deletion – Equivalence Indicator
12549L | Ordine 5, XT – MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL |
Deletion – Note
12549L | MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL (Ordine 5) |
Advance Notices
1 June 2025
Deletion – Brand
14084G | pms-HYDROmorphone, DZ – HYDROMORPHONE, hydromorphone hydrochloride 1 mg/mL oral liquid, 500 mL |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Item
14804E | EDARAVONE, edaravone 30 mg/20 mL injection, 10 x 20 mL ampoules (Radicava) |
14787G | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 actuations (Spravato) |
14798W | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations (Spravato) |
14811M | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 actuations (Spravato) |
14814Q | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations (Spravato) |
14823E | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations (Spravato) |
14831N | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations (Spravato) |
14828K | MACITENTAN + TADALAFIL, macitentan 10 mg + tadalafil 40 mg tablet, 30 (Opsynvi) |
14829L | VUTRISIRAN, vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra) |
Addition – Brand
12784W | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13033Y | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13038F | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13039G | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13040H | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
6100C | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
6138C | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
12146G | Bosentan Viatris, AL – BOSENTAN, bosentan 125 mg tablet, 60 |
6430K | Bosentan Viatris, AL – BOSENTAN, bosentan 125 mg tablet, 60 |
Deletions
Deletion – Note
14106K | DIFELIKEFALIN, difelikefalin 50 microgram/mL injection, 12 x 1 mL vials (Korsuva) |
14136B | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
14127M | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
Deletion – Restriction
14106K | DIFELIKEFALIN, difelikefalin 50 microgram/mL injection, 12 x 1 mL vials (Korsuva) |
Alterations
Alteration – Note
10184B | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
13724H | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Renflexis) |
13778E | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Renflexis) |
6397Q | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
6448J | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
6496X | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
9612X | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
9613Y | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
9617E | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
9674E | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
Alteration – Restriction
14136B | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
14127M | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
Advance Notices
1 June 2025
Deletion – Brand
12335F | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13229G | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12784W | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13033Y | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13038F | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13039G | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13040H | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
6100C | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
6138C | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
6352H | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 25 mg capsule, 30 |
6353J | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 50 mg capsule, 30 |
6354K | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 100 mg capsule, 30 |
1 July 2025
Deletion – Brand
11838C | Sevelamer Apotex, TX – SEVELAMER, sevelamer carbonate 800 mg tablet, 180 |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Item
14805F | EDARAVONE, edaravone 30 mg/20 mL injection, 10 x 20 mL ampoules (Radicava) |
14813P | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations (Spravato) |
14816T | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 actuations (Spravato) |
14821C | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations (Spravato) |
14822D | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 actuations (Spravato) |
14835T | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations (Spravato) |
14837X | ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations (Spravato) |
14785E | MACITENTAN + TADALAFIL, macitentan 10 mg + tadalafil 40 mg tablet, 30 (Opsynvi) |
14810L | VUTRISIRAN, vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra) |
Addition – Brand
12771E | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13028Q | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13036D | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13042K | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13044M | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
9597D | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
9598E | Azacitidine SXP, XN – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
12149K | Bosentan Viatris, AL – BOSENTAN, bosentan 125 mg tablet, 60 |
5619R | Bosentan Viatris, AL – BOSENTAN, bosentan 125 mg tablet, 60 |
Deletions
Deletion – Note
14141G | DIFELIKEFALIN, difelikefalin 50 microgram/mL injection, 12 x 1 mL vials (Korsuva) |
14128N | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
14131R | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
Deletion – Restriction
14141G | DIFELIKEFALIN, difelikefalin 50 microgram/mL injection, 12 x 1 mL vials (Korsuva) |
Alterations
Alteration – Note
10196P | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
13723G | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Renflexis) |
13765L | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Renflexis) |
5753T | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
5754W | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
5755X | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
5756Y | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
5757B | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
5758C | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
9654D | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
Alteration – Restriction
14128N | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
14131R | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
Advance Notices
1 June 2025
Deletion – Brand
12444Y | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
13212J | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
12771E | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13028Q | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13036D | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13042K | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
13044M | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
9597D | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
9598E | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
5634M | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 25 mg capsule, 30 |
5635N | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 50 mg capsule, 30 |
5636P | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 100 mg capsule, 30 |
1 July 2025
Deletion – Brand
11855Y | Sevelamer Apotex, TX – SEVELAMER, sevelamer carbonate 800 mg tablet, 180 |
Highly Specialised Drugs Program (Community Access)
Additions
Addition – Item
14806G | EDARAVONE, edaravone 30 mg/20 mL injection, 10 x 20 mL ampoules (Radicava) |
Addition – Brand
10347N | TENOFOVIR/EMTRICITABINE 300/200 APX, XW – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
Deletions
Deletion – Item
13777D | ADEFOVIR, adefovir dipivoxil 10 mg tablet, 30 (Adefovir Dipivoxil Tablets 10 mg (SigmaPharm Laboratories)) |
Advance Notices
1 August 2025
Deletion – Brand
10310P | Tenofovir APOTEX, TX – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
11992E | Tenofovir APOTEX, TX – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
IVF Program
Additions
Addition – Brand
9583J | Ganirelix Lupin, GQ – GANIRELIX, ganirelix 250 microgram/0.5 mL injection, 0.5 mL syringe |
9584K | Ganirelix Lupin, GQ – GANIRELIX, ganirelix 250 microgram/0.5 mL injection, 5 x 0.5 mL syringes |
Deletions
Deletion – Brand
6335K | Recagon, OV – FOLLITROPIN BETA, follitropin beta 300 units/0.36 mL injection, 0.36 mL cartridge |
6464F | Recagon, OV – FOLLITROPIN BETA, follitropin beta 900 units/1.08 mL injection, 1.08 mL cartridge |
Deletion – Equivalence Indicator
6335K | Puregon 300 IU/0.36 mL, OQ – FOLLITROPIN BETA, follitropin beta 300 units/0.36 mL injection, 0.36 mL cartridge |
6464F | Puregon 900 IU/1.08 mL, OQ – FOLLITROPIN BETA, follitropin beta 900 units/1.08 mL injection, 1.08 mL cartridge |
Alterations
Alteration – Note
10861P | FOLLITROPIN ALFA, follitropin alfa 75 units (5.5 microgram)/0.125 mL injection, 5 x 0.125 mL pen devices (Bemfola) |
10873G | FOLLITROPIN ALFA, follitropin alfa 150 units (11 microgram)/0.25 mL injection, 5 x 0.25 mL pen devices (Bemfola) |
10872F | FOLLITROPIN ALFA, follitropin alfa 225 units (16.5 microgram)/0.375 mL injection, 5 x 0.375 mL pen devices (Bemfola) |
10866X | FOLLITROPIN ALFA, follitropin alfa 300 units (22 microgram)/0.5 mL injection, 5 x 0.5 mL pen devices (Bemfola) |
12779N | FOLLITROPIN ALFA, follitropin alfa 300 units (22 microgram)/0.5 mL injection, 0.5 mL cartridge (Ovaleap) |
6431L | FOLLITROPIN ALFA, follitropin alfa 300 units (21.84 microgram)/0.48 mL injection, 0.48 mL pen device (Gonal-f Pen) |
10867Y | FOLLITROPIN ALFA, follitropin alfa 450 units (33 microgram)/0.75 mL injection, 5 x 0.75 mL pen devices (Bemfola) |
12800Q | FOLLITROPIN ALFA, follitropin alfa 450 units (33 microgram)/0.75 mL injection, 0.75 mL cartridge (Ovaleap) |
6432M | FOLLITROPIN ALFA, follitropin alfa 450 units (32.76 microgram)/0.72 mL injection, 0.72 mL pen device (Gonal-f Pen) |
12770D | FOLLITROPIN ALFA, follitropin alfa 900 units (66 microgram)/1.5 mL injection, 1.5 mL cartridge (Ovaleap) |
6433N | FOLLITROPIN ALFA, follitropin alfa 900 units (65.52 microgram)/1.44 mL injection, 1.44 mL pen device (Gonal-f Pen) |
Repatriation Pharmaceutical Benefits
Advance Notices
1 June 2025
Deletion – Brand
4092J | Budamax Aqueous, JT – BUDESONIDE, budesonide 64 microgram/actuation nasal spray, 120 actuations |
4518T | Orabase, AS – GELATIN + PECTIN + CARMELLOSE SODIUM, gelatin 16.7% + pectin 16.7% + carmellose sodium 16.7% paste, 5 g |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Item
14802C |
AMIVANTAMAB, amivantamab 350 mg/7 mL injection, 7 mL vial (Rybrevant) |
14807H |
AMIVANTAMAB, amivantamab 350 mg/7 mL injection, 7 mL vial (Rybrevant) |
Deletions
Deletion – Note
14109N |
DOSTARLIMAB, dostarlimab 500 mg/10 mL injection, 10 mL vial (Jemperli) |
Deletion – Restriction
14109N |
DOSTARLIMAB, dostarlimab 500 mg/10 mL injection, 10 mL vial (Jemperli) |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Item
14800Y |
AMIVANTAMAB, amivantamab 350 mg/7 mL injection, 7 mL vial (Rybrevant) |
14801B |
AMIVANTAMAB, amivantamab 350 mg/7 mL injection, 7 mL vial (Rybrevant) |
Deletions
Deletion – Note
14130Q |
DOSTARLIMAB, dostarlimab 500 mg/10 mL injection, 10 mL vial (Jemperli) |
Deletion – Restriction
14130Q |
DOSTARLIMAB, dostarlimab 500 mg/10 mL injection, 10 mL vial (Jemperli) |
Related Pharmaceutical Benefits for Public Hospital use
Additions
Addition – Item
14803D | EPCORITAMAB, epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
14826H | EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
14827J | EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
Advance Notices
1 June 2025
Deletion – Brand
5858H | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 8 mg orally disintegrating tablet, 4 |
5967C | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 4 mg tablet, 4 |
5968D | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 8 mg tablet, 4 |